Printer Friendly

Browse Metastasis topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Researchers at Cancer Treatment Centers of America' in Suburban Chicago Evaluating Investigational Medication for HER2-Positive Breast Cancer. Clinical report May 24, 2018 754
BBC presenter Rachael Bland reveals devastating 'incurable' cancer diagnosis and how trial drugs have 'turned her into a lab rat'; The You, Me and the Big C podcast co-host revealed she is taking a new trial drug after being told her cancer was metastatic. May 22, 2018 451
Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. May 21, 2018 202
Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. May 21, 2018 198
Switzerland : Phase III IMpower150 study showed Roches Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel. May 18, 2018 480
Switzerland : Follow-up phase III data showed Roches Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death. May 18, 2018 413
Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. May 14, 2018 306
Switzerland : Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal cancer. May 12, 2018 305
Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. May 11, 2018 306
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 187
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 183
Parenting concerns affect mothers with cancer:Study. May 9, 2018 319
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 207
Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. May 9, 2018 263
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 203
Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. May 9, 2018 259
Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy. Liu, Shuai; Chen, Peng; Liu, Yan-Wei; Gu, Xue-Nan; Qiu, Xiao-Guang; Li, Bo Report May 9, 2018 4742
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 255
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 251
Switzerland : FDA grants priority review to Roches cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer. May 8, 2018 275
Is protein responsible for breast cancer? May 7, 2018 395
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers. Clinical report May 4, 2018 1254
Taiwanese scientists isolate gene that spurs spread of cancer. May 3, 2018 395
The role of neutrophil-lymphocyte ratio as a prognostic indicator in patients undergoing nephrectomy for renal cell carcinoma. Grimes, Nathan; Hannan, Cathal; Tyson, Matthew; Thwaini, Ali Brief article May 2, 2018 2533
Inaugural Chicago Metsquerade on May 11 - A Fundraiser for Stage IV Breast Cancer Research. May 1, 2018 553
Evaluating the role for renal biopsy in T1 and T2 renal masses: A single-centre study. Hoare, Dylan; Evans, Howard; Richards, Heidi; Samji, Rahim Report Apr 28, 2018 3558
Replacement Planting In The Metastases-riem, Landscaping Works. Apr 27, 2018 126
LIVE FOR TODAY; Running with terminal cancer by Kevin Webber. Apr 22, 2018 334
United Kingdom : Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR. Apr 21, 2018 363
amcure Pre-Clinical Data on AMC303's Anti-tumor and Anti-Metastatic Effects Presented at AACR. Apr 20, 2018 280
AstraZeneca says FDA approves Tagrisso as 1st-line treatment for certain cancers. Apr 19, 2018 106
Zulekha uses new technique for cancer treatment. Apr 19, 2018 418
Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. Apr 19, 2018 360
Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. Apr 19, 2018 364
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway. Apr 18, 2018 1401
DNA Methylation and Uveal Melanoma. Yang, Zhi-Kun; Yang, Jing-Yun; Xu, Zhuo-Zai; Yu, Wei-Hong Report Apr 15, 2018 4732
The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab. Apr 11, 2018 1280
FINE NEEDLE ASPIRATION CYTOLOGY OF LYMPH NODES WITH HISTOLOGICAL CORRELATION--A STUDY OF 1033 CONSECUTIVE CASES, A SOUTH INDIAN STUDY. Gudibande, Tejaswini; Udupa K., Aniruddha; Puranik B., Rekha Report Apr 9, 2018 3842
The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection? Lam, Cameron Jonathan; Kapoor, Anil Report Apr 6, 2018 2709
Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Karakiewicz, Pierre I.; Zaffuto, Emanuele; Kapoor, Anil; Basappa, Naveen S.; Bjarnason, Georg A.; Bl Report Apr 6, 2018 4565
EMA Accepts Regulatory Submission for Lynparza (olaparib) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer. Apr 6, 2018 399
William Blair downgrades Incyte after metastatic melanoma study failure. Apr 6, 2018 152
Nerlynx (neratinib) in Combination With Capecitabine or Paclitaxel Included in NCCN Guidelines as Treatment Option for Patients With Breast Cancer Brain Metastases. Apr 5, 2018 183
Singapore : Calix Senior Director Bernd Hesse Elected to Broadband Forum Board of Directors. Apr 4, 2018 668
United States : The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer. Apr 4, 2018 255
Medicare Issues Local Draft Coverage Supporting Use of Cell-based Liquid Biopsy Test in Patients with Metastatic CRPC. Apr 3, 2018 313
Singapore : NUS scientists develop novel patient cancer cell culture test kit for personalised, precise cancer therapy. Apr 3, 2018 668
Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin/[Ca.sup.2+] Mobilizasyonu ve Akt Inhibisyonu ile PEO-1 Hucrelerinin Fibronektine Baglanmasinda Azalma. Kilicaslan, Seda Mehtap Sari; Ayrim, Aysun; Apaydin, Elif; Incesu, Zemin Apr 1, 2018 4503
Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort. Qu, X. Melody; Siemens, D. Robert; Louie, Alexander V.; Yip, Darwin; Mahmud, Aamer Report Apr 1, 2018 4926
Risky Alternatives. Brief article Apr 1, 2018 143
Bristol-Myers Squibb Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Certain Metastatic Colorectal Cancer Patients Accepted by US FDA for Priority Review. Mar 29, 2018 280
FDA Grants Breakthrough Therapy Designation to Seattle Genetics and Astellas for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Mar 28, 2018 320
United States : U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibbs Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Previously Treated Patients with MSI-H or dMMR Metastatic Colorectal Cancer for Priority Review. Mar 28, 2018 296
United States : Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Mar 28, 2018 380
A CLINICO-PATHOLOGICAL STUDY OF SQUAMOUS CELL CARCINOMA OF GINGIVOBUCCAL COMPLEX IN PUNJAB. Pervej, Khurshid; Singh, Manjit; Singh, Baldev; Kundai, Ramesh Kumar; Singh, Anmol Report Mar 26, 2018 3334
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 229
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 225
Pfizer, Astellas Seek to Expand Indication of Xtandi to include Men with Non-metastatic CRPC. Mar 21, 2018 304
Astex Collaborator Janssen Receives US FDA Breakthrough Therapy Designation for Erdafitinib for Metastatic Urothelial Cancer. Mar 20, 2018 235
Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. Mar 20, 2018 254
Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. Mar 20, 2018 258
United States : U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC). Mar 20, 2018 456
Pulmonary Metastasis of a Gigantic Cystosarcoma Phyllodes of the Breast. Gao, Yan-Hong; Xiang, Hui-Juan; Zhu, Jian; Duan, Yun; Zhou, Pei Clinical report Mar 18, 2018 771
Primary Pulmonary Germ Cell Tumor with Bone Metastasis. Li, Tong-Tong; Yan, Xu; Zhou, Tong; Liu, Ying; Yu, Zhen-Xiang Clinical report Mar 18, 2018 1175
Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. Mar 16, 2018 253
Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. Mar 16, 2018 249
United States : Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer. Mar 16, 2018 259
IO Biotech and MSD Partner to Evaluate IO102 in combination with Keytruda (pembrolizumab) in Patients with Metastatic NSCLC. Mar 14, 2018 265
United States : Seattle Genetics Completes Acquisition of Cascadian Therapeutics. Mar 14, 2018 403
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 294
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 295
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 290
Seattle Genetics completes Cascadian acquisition, getsTucatinib rights. Mar 9, 2018 288
Sorrento Therapeutics says CAR-T cell therapy demonstrates therapeutic activity. Mar 5, 2018 387
DISTAL PANCREATECTOMY IN THE SURGICAL TREATMENT OF PANCREATIC CANCER--A STUDY. Choudhury, Purujit Report Mar 5, 2018 2868
Extraskeletal Myxoid Chondrosarcoma of Nasopharynx: An Oncologic Entity Rarely Reported. Purkayastha, Abhishek; Sharma, Neelam; Dutta, Vibha Report Mar 1, 2018 1557
Neoadjuvant data promising, role unclear. Mar 1, 2018 313
Genomic Health Launches Liquid Biopsy Test to Predict Treatment Response in Metastatic Castration-resistant Prostate Cancer. Mar 1, 2018 285
First Patient Dosed in Merrimack Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer. Clinical report Mar 1, 2018 257
Sustained Ventricular Tachycardia Secondary to Cardiac Metastasis of Lung Cancer. Li, Ying-Ying; Wang, Hua; Cui, Ya-Dong; Liu, Hang-Yu; Yang, Jie-Fu Case study Mar 1, 2018 1192
Metastatic adenocarcinoma involving atypical meningioma. Agostini-Vulaj, Diana; Rosella, Peter; Yeaney, Gabrielle Case study Mar 1, 2018 1143
Appendiceal and rectal carcinomas with Krukenberg tumour mimicking primary ovarian cancer. Feb 28, 2018 1558
MetaStat announces completion of pilot research project with Celgene. Feb 28, 2018 187
Eli Lilly receives additional FDA approval for Verzenio. Feb 26, 2018 139
United States : ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc. Feb 22, 2018 362
United States : Advaxis Submits Conditional Marketing Authorization Application For Axalimogene Filolisbac For The Second-Line Treatment Of Metastatic Cervical Cancer In European Union. Feb 19, 2018 500
STUDY OF HISTOMORPHOLOGY AND IMMUNOHISTOCHEMICAL ANALYSIS IN BREAST NEOPLASM. Kaushal, Manish; Shukla, Arvind; Patil, Pankaj Report Feb 19, 2018 2246
Results of Phase II Trial of Durvalumab in Recurrent or Metastatic Head and Neck Cancer with Low or Negative Expression of PD-L1 Protein Presented at 2018 Multidisciplinary Head and Neck Cancers Symposium. Feb 16, 2018 308
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 304
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 300
Janssen Files MAA for Apalutamide for Treatment of High-Risk Non-Metastatic CRPC in Europe. Feb 14, 2018 282
United States : Apalutamide helps delay spread of several prostate cancers in phase 3 clinical trial. Feb 13, 2018 306
Combatcancer: Rational combination therapies for metastatic cancer. Feb 12, 2018 372
DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT THYROID NODULE WITH DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING AND APPARENT DIFFUSION COEFFICIENT MEASUREMENTS AND ITS HISTOPATHOLOGICAL CORRELATION. M., Noufal P.; Ramakrishnan, K.G.; Kurup, Shailage; Ali, Naseer; Janardhanan, Sujith; Rabia, Tejmal Report Feb 12, 2018 5590
Xtandi Plus ADT Reduces Risk of Metastasis, Death, PSA Progression in Men with CRPC Compared to ADT Alone. Feb 9, 2018 420
United States : ZYTIGA (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer. Feb 9, 2018 543
United States : ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Feb 9, 2018 297
Germany : Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium. Feb 8, 2018 479
Japan : Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Feb 8, 2018 352
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 215
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 211
Astellas Pharma, Pfizer announce results from Phase 3 PROSPER trial. Feb 5, 2018 164
USPTO Grants Skin Biology Patent for Non-toxic Skin Cancer Therapy with Copper Peptides. Feb 2, 2018 152
FDA GRANTS FAST TRACK DESIGNATION TO ANTI-HER2. Feb 1, 2018 878
Radiotherapy for Gastrointestinal Stromal Tumors. Ozkan, Emine Report Feb 1, 2018 6095
Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. Brand, M.; Gaylard, P.; Ramos, J. Report Feb 1, 2018 3512
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer--A Canadian consensus statement. Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret Report Feb 1, 2018 6012
Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret Feb 1, 2018 1364
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Khalaf, Daniel Joseph; Aviles, Claudia M.; Azad, Arun A.; Sunderland, Katherine; Todenhofer, Tilman; Report Feb 1, 2018 4584
Association between life events after diagnosis of breast cancer and metastasis. Dourado, Claudia de Souza; de Souza, Camila Brandao; de Castro, Denise Silveira; Zandonade, Eliana; Feb 1, 2018 5435
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 131
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 127
FDA Grants Synthon Fast Track Designation for Anti-HER2 ADC for Pre-treated HER2-positive Metastatic Breast Cancer. Jan 29, 2018 208
Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. Jan 24, 2018 436
Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. Jan 24, 2018 362
Exelixis Presents Phase 1b Results for Cobimetinib plus Atezolizumab in Metastatic Colorectal Cancer at the 2018 ASCO Gastrointestinal Cancers Symposium. Jan 23, 2018 443
United States : European Commission Approves Bristol-Myers Squibbs Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Jan 23, 2018 288
Opdivo plus Yervoy Shows 55% ORR at 13.4 Months in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 328
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 380
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 260
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 261
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 256
Amgen and Allergan's Mvasi for certain cancers approved in Europe. Jan 18, 2018 114
US FDA Approves Lynparza (olaparib) for Germline BRCA-Mutated Metastatic Breast Cancer. Jan 17, 2018 492
CytRx begins dosing in clinical trial for metastatic pancreatic cancer candidate. Jan 17, 2018 141
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 207
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 347
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 343
AstraZeneca and Merck announces FDA approval of Lynparza for metastatic breast cancer. Jan 15, 2018 431
Canada,United States : U.S. FDA Approves LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer. Jan 14, 2018 700
Eisai and Merck & Co. Receive Breakthrough Therapy Designation from U.S. FDA for LENVIMA and KEYTRUDA. Jan 9, 2018 1432
Bad cholesterol helps cancer spread. Jan 3, 2018 226
New Biomarker Predicts Metastatic Prostate Cancers. Jan 1, 2018 220
Personalized medicine offers new hope to breast cancer patients. Jan 1, 2018 2236
Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies. Akinlolu, Abdulazeez; Salau, Bamidele; Odewabi, Adesina; Biliaminu, Sikiru; Abdulazeez, Ishola Report Jan 1, 2018 2489
Papillary Carcinoma of Thyroid with Nasal Cavity Metastases: A Case Report. Pourseirafi, Saeid; Shishehgar, Mahmood; Ashraf, Mohammad Javad; Faramarzi, Mohammad Case study Jan 1, 2018 1640
EVALUATION OF HISTOPATHOLOGICAL RISK FACTORS IN ENUCLEATED RETINOBLASTOMA EYES. Acharya, Nibedita; Vasu, Usha Report Jan 1, 2018 2071
Amgen's sBLA for XGEVA (denosumab) to expand the currently approved indication for the prevention of skeletal-related events in patients with bone metastases from solid tumors, has been approved to include multiple myeloma. Jan 1, 2018 217
Transrectal ultrasound-guided prostate biopsies vs. magnetic resonance imaging ultrasound fusion targeted biopsies: Who are the best candidates? Bey, Elsa; Gaget, Olivier; Descotes, Jean-Luc; Franquet, Quentin; Rambeaud, Jean-Jacques; Long, Jean Report Jan 1, 2018 3252
Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo Report Jan 1, 2018 3753
Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer Clinical report Jan 1, 2018 1729
Occurrence of squamous cell carcinoma in Milchschaf sheep in Uruguay/Ocorrencia do carcinoma de celulas escamosas em ovinos Milchschaf em Uruguai. Garcia, Juan Agustin; Quinteros, Carina; Romero, Agustin; Dutra, Fernando Jan 1, 2018 3023
Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, Report Jan 1, 2018 5456
Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells. Zhang, S.; Zhang, Y.; Qu, J.; Che, X.; Fan, Y.; Hou, K.; Guo, T.; Deng, G.; Song, N.; Li, C.; Wan, X Report Jan 1, 2018 4188
Odonate Therapeutics Begins Phase 3 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer. Dec 29, 2017 232
Janssen NDA for Apalutamide as Treatment for Non-Metastatic CRPC Garners Priority Review from US FDA. Dec 26, 2017 284
FDA approves Nanobiotix's first Immuno-Oncology trial. Dec 26, 2017 1718
Bad cholesterol can help cancer spread, scientists warn. Dec 23, 2017 207
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 282
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 278
United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease. Dec 21, 2017 303
CHMP Recommends Approval of Yervoy (ipilimumab) for the Treatment of Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Dec 19, 2017 351
CLINICOPATHOLOGICAL STUDY OF TUMOURS OF HYPOPHARYNX. Sadangi, Rajesh Kumar; Misra, Santosh Kumar Report Dec 11, 2017 2028
Eisai: Updated Analysis of Phase Ib/II Study of Eribulin and Pembrolizumab Combination Regimen. Dec 8, 2017 1455
Ibrance (palbociclib) plus Letrozole Improves Progression-Free Survival in ER+, HER2- Metastatic Breast Cancer. Dec 7, 2017 372
Preclinical Data Show Agilvax AX09 Immunotherapy Reduces Tumor Growth and Pulmonary Metastases in Triple Negative Breast Cancer. Dec 7, 2017 252
Fitbit Aids In Understanding Cancer Surgery Recovery Better. Dec 6, 2017 534
CYTOLOGIC PATTERNS OF LUNG CANCER. Prabha, Raj R.L.; Priya, P.V.; Sankar, S. Report Dec 4, 2017 2637
INCIDENCE OF CENTRAL NERVOUS SYSTEM TUMORS IN PATIENTS HOSPITALIZED AT SPLIT UNIVERSITY HOSPITAL CENTRE DURING A TEN-YEAR PERIOD (JANUARY 1, 2004 - DECEMBER 31, 2013). Mizdrak, Maja; Dzamonja, Gordan; Grcic, Petar Filipovic Report Dec 1, 2017 4754
RELAPSE OF PLEOMORPHIC ADENOMA FROM CHILDHOOD TO ADULTHOOD: CASE REPORT. Grabovac, Stjepan; Grabovac, Durdica; Puharic, Zrinka; Dalipi, Vesna Malcic Clinical report Dec 1, 2017 2620
Systemic Therapy after Radiotherapy Significantly Reduces the Risk of Mortality of Patients with 1-3 Brain Metastases: A Retrospective Study of 250 Patients. Li, Bo; Dai, Zhao-Xia; Chen, Yi-Dong; Liu, Yan-Wei; Liu, Shuai; Gu, Xue-Nan; Qiu, Xiao-Guang Dec 1, 2017 4164
Metastatic Melanoma - Pipeline Review, H2 2015 Now Available at iData Insights. Dec 1, 2017 1841
Germany : Phase III trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone for patients with metastatic castration-resistant prostate cancer unblinded early. Dec 1, 2017 346
The Effect of Resection Methods on Outcomes in Colorectal Cancers: Does Conversion Matter?/Kolorektal Kanserlerde Rezeksiyon Metodunun Sonuclara Etkisi: Konversiyon Onemli mi? Erdogdu, Umut Eren; Cayci, Haci Murat Report Dec 1, 2017 5032
Myeloid sarcoma of the thyroid. Goldenberg, Dana; Joshi, Monika; Malysz, Jozef; Claxton, David; Cottrill, Elizabeth E. Report Dec 1, 2017 867
Electrochemotherapy treatment of oral extramedullary plasmacytoma of the tongue: a retrospective study of three dogs/Eletroquimioterapia no tratamento de plasmocitoma extramedular oral na lingua: estudo retrospectivo de tres caes. Cunha, Rubia Monteiro de Castro; Lavalle, Gleidice Eunice; Caires, Carla Emanuela Tertuliano; de Ara Dec 1, 2017 2038
Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study. Gonzalez, Velda J.; Saligan, Leorey N.; Fridley, Brooke L.; Ortiz-Zuazaga, Humberto; Aaronson, Laure Dec 1, 2017 6201
Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus--Positive and Human Papillomavirus--Negative Tumors. Pirog, Edyta C. Report Dec 1, 2017 9920
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 236
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 237
CORRELATION OF COAGULATION MARKERS WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST. Choudhary, Ganpat Singh; Bairwa, Man Singh; Choudhary, Amit; Singodia, Rishi Report Nov 27, 2017 2433
European Commission Extends License for Janssen's Zytiga Plus Prednisone / Prednisolone to Include Earlier Stage Prostate Cancer Patients. Nov 22, 2017 263
Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma. Liao, Ji-Ping; Nie, Li-Gong; Que, Cheng-Li; Mu, Xiang-Dong Case study Nov 20, 2017 1267
A key to stopping cancer in its tracks. Nov 19, 2017 374
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 260
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 256
Germany : Novartis reports positive results from Phase III trial of Kisqali (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer. Nov 9, 2017 328
Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention. Li, Tian-Ran; Yu, Ming-Hui; Huang, Xiao-Bin; Yang, Zhi-Jie; Lu, Guang-Ming; Li, Yan-Jun Nov 5, 2017 5584
Impact of distant and regional metastasis of non-small-cell lung cancer on endotoxicosis development. Belskaya, Lyudmila V.; Kosenok, Viktor K.; Sarf, Elena A.; Zhuchkov, Sergey A. Nov 1, 2017 5176
Neuroendocrine Tumors of the Breast. Rosen, Lauren Elizabeth; Gattuso, Paolo Report Nov 1, 2017 3667
Myxoinflammatory Fibroblastic Sarcoma: Review and Update. Lucas, David R. Report Nov 1, 2017 2505
Metastatic endometrial serous carcinoma to the breast. Lin, Tayson; Lin, David; Zhang, Ziying; Shah, Biren A. Case study Nov 1, 2017 1108
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44. Oct 31, 2017 4267
De novo descending aorta thrombus in a patient with metastatic colorectal cancer: A case report. Oct 31, 2017 1434
Five-year Survival of Newly Diagnosed Stage Four Breast Cancer Has improved. Oct 30, 2017 389
Eagle Pharmaceuticals Receives Tentative FDA Approval for Pemfexy Ready-to-Dilute. Oct 30, 2017 299
A Tuberous Sclerosis Family with TSC1 (c.1030-1G>A) Mutation Found through a Female Presenting as Multiple Ground Glass Nodules in Chest Computed Tomography Incidentally. Zhao, Ting-Ting; Wang, Yong-Sheng; Li, Yan; Ma, Miao; Li, Ai-Mei; Cai, Hou-Rong; Fan, Xiang-Shan; Me Report Oct 20, 2017 1482
OncoSec Releases Data from Recently Completed Studies of ImmunoPulse IL-12 Monotherapy or in Combination with Pembrolizumab in Metastatic Melanoma Patients. Oct 20, 2017 428
Pfizer Study of ALK-Inhibitor Lorlatinib Shows Positive Results Against NSCLC Tumors and Brain Metastases. Oct 18, 2017 409
Protein Biomarker Heterogeneity Observed in Metastatic Breast Cancer Patients. Clinical report Oct 16, 2017 266
US FDA receives new drug application from Janssen Biotech for Apalutamide. Oct 13, 2017 166
United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 394
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 244
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 240
Janssen Submits NDA to US FDA for Apalutamide for Treatment of Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 197
OncoSec Begins Enrollment in Clinical Trial of ImmunoPulse IL-12 in Combination with Keytruda (pembrolizumab) in Patients with Unresectable Metastatic Melanoma. Oct 11, 2017 349
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? Oct 2, 2017 743
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells?. Oct 2, 2017 749
Chemo causes disease to spread to lungs. Oct 1, 2017 322
Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions. Singh, Reena; Cho, Kathleen R. Report Oct 1, 2017 2171
Rare case of angiosarcoma of the adrenal gland seen with multiple modalities. Varkey, Jastin; Astani, Seyed Amin; Pantelic, Milan; Dalal, Ishani Case study Oct 1, 2017 1283
Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5. Yu, Z.; Cheng, H.; Zhu, H.; Cao, M.; Lu, C.; Bao, S.; Pan, Y.; Li, Y. Report Oct 1, 2017 3818
Eli Lilly and Company awarded US FDA approval for Verzenio for the treatment of advanced or metastatic breast cancer. Sep 29, 2017 334
Claim for missed cancer diagnosis goes back to jury. Donovan, David Sep 27, 2017 672
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? Nagrath, Sunitha Sep 25, 2017 743
Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 22, 2017 713
Metastatic Breast Cancer Treatment. Brief article Sep 22, 2017 222
Merck KGaA & Pfizer Inc partnership win EC's marketing authorisation for BAVENCIO for metastatic merkel cell carcinoma. Sep 21, 2017 317
United States : Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer. Sep 16, 2017 355
United States : FDA Approves Amgen And Allergan's MVASI (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer. Sep 15, 2017 390
United States : Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Sep 15, 2017 475
Bavarian Nordic to discontinue Phase 3 Study of PROSTVAC in metastatic prostate cancer. Sep 15, 2017 190
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 320
Bavarian Nordic to discontinue Phase 3 Study of PROSTVAC in metastatic prostate cancer. Sep 15, 2017 186
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 316
Bristol-Myers Squibb Touts Positive Study Data for Opdivo, Yervoy Combination in Advanced or Metastatic Renal Cell Carcinom. Sep 12, 2017 384
Data from Pfizer Study of Trastuzumab Biosimilar Demonstrates Equivalence in ORR for Patients with HER2-positive Metastatic Breast Cancer. Clinical report Sep 12, 2017 319
United States : Lilly Builds Upon Body of Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer. Clinical report Sep 11, 2017 486
Belgium : New Data Presented at ESMO 2017 Shows That Abiraterone Acetate Plus Prednisone Provides Benefits in Patient Reported Outcomes in Both Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer. Sep 10, 2017 163
United States : CheckMate -214 Study Evaluating Opdivo in Combination with Yervoy Stopped Early for Demonstrating Overall Survival Benefit in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Sep 8, 2017 200
Israel : Life-Prolonging Treatment for Metastatic Non-Small Cell Lung Cancer Approved for Clinical Trials. Sep 1, 2017 422
Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience. Botsa, Evanthia; Thanou, Ioanna; Papatheodoropoulou, Aspasia; Thanos, Loukas Report Sep 1, 2017 3228
Clinicopathological Characteristics of Papillary Thyroid Cancer in Children with Emphasis on Pubertal Status and Association with [BRAF.sup.V600E] Mutation. Poyrazoglu, Sukran; Bundak, Ruveyde; Bas, Firdevs; Yegen, Gulcin; Sanli, Yasemin; Darendeliler, Feyz Report Sep 1, 2017 6123
Management of Childhood Thyroid Nodules: Surgical and Endocrinological Findings in a Large Group of Cases. Divarci, Emre; Celtik, Ulgen; Dokumcu, Zafer; Ergun, Orkan; Ozok, Geylani; Ozen, Samim; Simsek, Daml Report Sep 1, 2017 4225
Ben Stiller Wants Men to Test for Prostate Cancer. Vanzile, Jon Sep 1, 2017 2748
Aspirin Fights Cancer. Brief article Sep 1, 2017 279
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS)/Asociacion de Particion Hepatica y Ligadura Portal para Hepatectomia por Etapas (ALPPS). Manterota, Carlos; Otzen, Tamara Sep 1, 2017 5312
Terapia con [[sup.177]Lu--Dota0--[Tyr.sup.3]]-Octreotate ([sup.177]Lu-Dotatate) en pacientes con tumores avanzados de origen neuroendocrino: experiencia inicial y resultados preliminares. Marin-Oyaga, Victor; Gutierrez-Villamil, Claudia; Mejia-Lopez, Arturo; Valenzuela-Rincon, Alex; Sanc Sep 1, 2017 3844
Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital. Aug 31, 2017 4888
Role of surgery in brain metastases. Aug 31, 2017 1315
Castle Biosciences Study of Melanoma Test Demonstrates Improved Clinical Risk Assessment. Clinical report Aug 30, 2017 257
Unusual case of angiosarcoma of liver presenting with pulmonary metastasis in a young girl. Daspin, D.; Aby, Tom; Sivaraman, Ramalingam; Francis, G. Case study Aug 28, 2017 1210
Switzerland : Novartis Kisqali (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor. Aug 28, 2017 358
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 235
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 231
United States : Bristol-Myers Squibb Announces Topline Results from CheckMate -214, a Phase 3 Study of Opdivo in Combination with Yervoy in Intermediate and Poor-Risk Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Aug 16, 2017 324
Comparison of who and recist response criteria in locally advanced breast cancer--a descriptive study. Sundararaju, Vishnu Kumar Report Aug 14, 2017 2717
Madison Vaccines Doses First Patient in Trial of MVI-816 Plus Keytruda for Metastatic, Treatment-Resistant Prostate Cancer. Aug 4, 2017 308
New drug 'cuts cancer tumours by up to half'. Aug 3, 2017 170
United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in MSI-H or dMMR Metastatic Colorectal Cancer That Has Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin, and Irinotecan. Aug 2, 2017 475
Update on Immunohistochemical Analysis in Breast Lesions. Peng, Yan; Butt, Yasmeen M.; Chen, Beiyun; Zhang, Xinmin; Tang, Ping Report Aug 1, 2017 10899
Application of Immunohistochemistry in Undifferentiated Neoplasms: A Practical Approach. Kandukuri, Shivani R.; Lin, Fan; MD; Gui, Lizhen; Gong, Yun; Fan, Fang; Chen, Longwen; Cai, Guoping; Aug 1, 2017 11483
Immune therapy durable in melanoma brain metastases. Oakes, Kari Clinical report Aug 1, 2017 773
The molecular basis of prostate cancer and targeting therapies. Jurasunas, Serge Report Aug 1, 2017 7994
Ocular metastasis as initial presentation in breast cancer. Maliepaard, M.; Mesham, M.; Aleksic, Z.; Scholtz, R.; Edge, J. Clinical report Aug 1, 2017 1572
Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-[beta]1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers/Endometrial ve Ovaryum Kanserinde Tanisal Deger Yonunden Serum Biyobelirteci Olarak Vitronektin, Solubl Epitel-Kaderin ve TGF-[beta]1'in Degerlendirilmesi. Turan, Taylan; Torun, Meral; Atalay, Funda; Gonenc, Aymelek Report Aug 1, 2017 4480
Radiation therapy--an effective tool for analgesia in metastatic bone disease in breast cancer. Negi, Preety; Kingsley, Pamela Alice; Sachdeva, Jaineet; Srivastava, Himanshu Report Jul 31, 2017 2888
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 277
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 273
Prognostic Analysis of 102 Patients with Synchronous Colorectal Cancer and Liver Metastases Treated with Simultaneous Resection. Zhang, Ye-Fan; Mao, Rui; Chen, Xiao; Zhao, Jian-Jun; Bi, Xin-Yu; Li, Zhi-Yu; Zhou, Jian-Guo; Zhao, H Clinical report Jul 27, 2017 2435
Using Ultrasonography to Evaluate the Relationship between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas. Jiao, Wei-Ping; Zhang, Lei Clinical report Jul 27, 2017 2816
Neon Therapeutics, Apexigen to Collaborate in Clinical Trial for Metastatic Melanoma Treatment. Jul 26, 2017 289
US FDA Approves Bristol-Myers Squibb's Yervoy for Treatment of Adolescents with Unresectable or Metastatic Melanoma. Jul 25, 2017 470
Germany,United States : EMAs CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. Jul 22, 2017 592
FDA Grants Priority Review for Lilly's Abemaciclib in Advanced Breast Cancer. Jul 11, 2017 441
PDS biotechnology and Merck Subsidiary to Collaborate to Evaluate Versamune PDS0101 and Keytruda (pembrolizumab) Combination for Metastatic Head and Neck Cancer. Jul 11, 2017 266
Puma biotechnology Trial of Neratinib in Metastatic Breast Cancer Completes Targeted Enrollment. Jul 7, 2017 275
CTC4BMP: Circulating tumor cells for tailoring BMP targeted therapies. Jul 7, 2017 234
Future Cancer Treatment Could Stop Disease From Spreading. Jul 3, 2017 574
Renal salt wasting syndrome in a patient receiving cisplatin chemotherapy for metastatic testicular cancer: a case report. Anderson, Christine; Linington, Ashley Clinical report Jul 1, 2017 3118
Immediate-completion lymph node dissection in metastatic melanoma. Moon, Mary Ann Jul 1, 2017 589
Feminizing adrenocortical carcinoma without gynecomastia. Chentli, Farida; Chabour, Fadila; Bouchibane, Djafer; Nouar, Nouria Case study Jul 1, 2017 1320
Metastatic mammary carcinoma in a cow/Carcinoma metastatico mamario em uma vaca. Piva, Manoela Marchezan; Schwertz, Claiton Ismael; Henker, Luan Cleber; Millan, Yolanda; de las Mula Jul 1, 2017 2143
Survival rates rise for younger women with de novo MBC. Osterweil, Neil Jul 1, 2017 546
Is sentinel lymph node mapping associated with acceptable performance characteristics for the detection of nodal metastases in women with endometrial cancer? Wright, Jason D. Jul 1, 2017 805
Effectiveness and safety of percutaneous vertebroplasty in the treatment of spinal metastatic tumor. Jun 30, 2017 3036
Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer. Report Jun 30, 2017 3527
Exelixis Starts Phase 1b Trial of Cabozantinib, Atezolizumab Combination in Locally Advanced or Metastatic Solid Tumors. Jun 14, 2017 568
United States : Q BioMed Announces Attendance at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. Jun 10, 2017 293
United States : Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 10, 2017 337
United States : Celldex Presents Promising Overall Survival Data from Phase 2 Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory Metastatic Melanoma. Clinical report Jun 10, 2017 846
OncoSec wins US FDA's orphan drug designation for tavokinogene telsaplasmid to treat unresectable metastatic melanoma. Jun 9, 2017 253
Novartis partners with Bristol-Myers Squibb to investigate Mekinist in combination with Opdivo and Opdivo + Yervoy regimen for treating metastatic colorectal cancer. Jun 6, 2017 310
Novartis partners with Bristol-Myers Squibb to investigate Mekinist in combination with Opdivo and Opdivo + Yervoy regimen for treating metastatic colorectal cancer. Jun 6, 2017 306
Novartis and Bristol-Myers Squibb team up in metastatic colorectal cancer clinical trial. Jun 6, 2017 230
Novartis and Bristol-Myers Squibb team up in metastatic colorectal cancer clinical trial. Jun 6, 2017 226
Merck Releases Results on Keytruda Studies in Metastatic Urothelial Carcinoma. Jun 6, 2017 374
Array BioPharma, Bristol-Myers Squibb Partner to Study Treatment Regimen for Metastatic Colorectal Cancer. Jun 5, 2017 355
United States : First Presentation of Efficacy Data from CheckMate -204 Evaluating the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab) Demonstrates Anti-tumor Activity in Advanced Melanoma Patients with Brain Metastases. Jun 5, 2017 557
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrated Promising Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer in Phase 2 CheckMate -142 Study. Jun 5, 2017 433
United States : Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer. Jun 5, 2017 520
How Can We Stop Cancer Cells From Spreading? Jun 5, 2017 575
Switzerland : Novartis presents updated data that reinforce the efficacy and safety of Kisqali (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer. Jun 3, 2017 350
Novartis provides updated data reinforcing efficacy and safety of Kisqali plus letrozole for HR+/HER2-advanced or metastatic breast cancer. Jun 2, 2017 304
Novartis provides updated data reinforcing efficacy and safety of Kisqali plus letrozole for HR+/HER2-advanced or metastatic breast cancer. Jun 2, 2017 300
Cancer. Jun 1, 2017 167
Liver transplantation for non-resectable colorectal liver metastases at a single centre in South Africa: a report of the ethics and regulatory approval process. Etheredge, H.R.; Botha, J.; Cleaton-Jones, P. Report Jun 1, 2017 1775
New research in kidney cancer, ASCO-GU 2017. Basappa, Naveen; Pouliot, Frederic Jun 1, 2017 1491
Matrix metalloproteinases in urinary system tumours. Part I - Matrix metalloproteinases in renal cell carcinoma. Mlynarczyk, G.; Kudelski, J.; Darewicz, B.; Galewska, Z.; Romanowicz, L. Report Jun 1, 2017 4872
Matrix metalloproteinases in urinary system tumors. Part II - Matrix metalloproteinases in urinary bladder carcinoma. Mlynarczyk, G.; Kudelski, J.; Darewicz, B.; Galewska, Z.; Romanowicz, L. Report Jun 1, 2017 3666
Metilacion de genes supresores de tumores en pacientes venezolanos con leucemia linfoide aguda. Brito Acosta, Rutmelania; Rojas de Atencio, Alicia; Prieto, Carem; Gonzalez Ferrer, Sandra; Urdaneta Ensayo Jun 1, 2017 4961
Early vulvar and umbilical incisional scar recurrence of cervical squamous cell carcinoma: Earlier than usually expected/Skuamoz hucreli servikal karsinomun erken vulvar ve umbilikal insizyonel skar rekurrensi: Beklenilenden daha erken. Ozcan, Huseyin Caglayan; Mustafa, Aynur; Bozdag, Zehra; Sucu, Seyhun; Ugur, Mete Gurol; Balat, Ozcan Report Jun 1, 2017 2051
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer. Zhang, Y.; Chen, Q. Report Jun 1, 2017 4633
Multiple Polypoid Colonic Metastases from Primary Gastric Signet Ring Cell Carcinoma. Zhang, Lu-Yang; Ma, Jun-Jun; Zang, Lu; Dong, Feng; He, Zi-Rui; Zheng, Min-Hua Report Jun 1, 2017 1275
United States : Advaxis and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate ADXS-DUAL and Opdivo (nivolumab) in Metastatic Cervical Cancer. May 31, 2017 329
FDA approves expanded use of Novartis drug Zykadia in first-line ALK-positive metastatic NSCLC. May 30, 2017 232
FDA approves expanded use of Novartis drug Zykadia in first-line ALK-positive metastatic NSCLC. May 30, 2017 228

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters